NO964070D0 - Lav-viskositets opthalmisk blanding - Google Patents

Lav-viskositets opthalmisk blanding

Info

Publication number
NO964070D0
NO964070D0 NO964070A NO964070A NO964070D0 NO 964070 D0 NO964070 D0 NO 964070D0 NO 964070 A NO964070 A NO 964070A NO 964070 A NO964070 A NO 964070A NO 964070 D0 NO964070 D0 NO 964070D0
Authority
NO
Norway
Prior art keywords
amount
pct
weight
viscosity
polymer
Prior art date
Application number
NO964070A
Other languages
English (en)
Other versions
NO964070L (no
NO314434B1 (no
Inventor
Timo Reunamaki
Kari Lehmussaari
Eija Vartiainen
Olli Oksala
Sakari Alaranta
Esko Pohjala
Original Assignee
Leiras Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leiras Oy filed Critical Leiras Oy
Publication of NO964070D0 publication Critical patent/NO964070D0/no
Publication of NO964070L publication Critical patent/NO964070L/no
Publication of NO314434B1 publication Critical patent/NO314434B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19964070A 1994-03-31 1996-09-27 Lav-viskositets oftalmisk blanding NO314434B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9401108A SE9401108D0 (sv) 1994-03-31 1994-03-31 Ophthalmic composition I
PCT/FI1995/000166 WO1995026711A1 (en) 1994-03-31 1995-03-29 Ophthalmic composition with decreased viscosity

Publications (3)

Publication Number Publication Date
NO964070D0 true NO964070D0 (no) 1996-09-27
NO964070L NO964070L (no) 1996-11-28
NO314434B1 NO314434B1 (no) 2003-03-24

Family

ID=20393511

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19964070A NO314434B1 (no) 1994-03-31 1996-09-27 Lav-viskositets oftalmisk blanding

Country Status (27)

Country Link
US (1) US5710182A (no)
EP (1) EP0752847B1 (no)
JP (1) JPH10503470A (no)
KR (1) KR100365914B1 (no)
CN (1) CN1112918C (no)
AT (1) ATE202921T1 (no)
AU (1) AU694497B2 (no)
BG (1) BG63145B1 (no)
BR (1) BR9507438A (no)
CA (1) CA2186734A1 (no)
CZ (1) CZ290987B6 (no)
DE (2) DE752847T1 (no)
DK (1) DK0752847T3 (no)
EE (1) EE03661B1 (no)
ES (1) ES2161874T3 (no)
GR (1) GR3036763T3 (no)
HK (1) HK1013953A1 (no)
HU (1) HU223071B1 (no)
MX (1) MX9603918A (no)
NO (1) NO314434B1 (no)
PL (1) PL179433B1 (no)
PT (1) PT752847E (no)
RO (1) RO115409B1 (no)
RU (1) RU2139016C1 (no)
SE (1) SE9401108D0 (no)
SK (1) SK280492B6 (no)
WO (1) WO1995026711A1 (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
WO2000064528A1 (en) 1999-04-28 2000-11-02 Situs Corporation Drug delivery system
US6852688B2 (en) 2000-03-10 2005-02-08 University Of Florida Compositions for treating diabetic retinopathy and methods of using same
AU2003213210A1 (en) * 2002-02-22 2003-09-09 Pharmacia Corporation Ophthalmic formulation with gum system
EP1484054B1 (en) * 2002-02-22 2012-08-29 Santen Pharmaceutical Co., Ltd. Drug delivery system for the subconjunctival administration of fine grains
CN100453066C (zh) * 2002-12-04 2009-01-21 参天制药株式会社 利用结膜下储存库的药物释放系统
JP2004196787A (ja) * 2002-12-04 2004-07-15 Santen Pharmaceut Co Ltd 結膜下デポによるドラッグデリバリーシステム
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
CA2839847C (en) * 2003-06-13 2016-03-15 Masood A. Chowhan Ophthalmic compositions containing a synergistic combination of two polymers
CA2536185C (en) * 2003-08-20 2012-06-26 Santen Pharmaceutical Co., Ltd. Drug delivery system by administrating fine particles to sub-tenon
TWI367098B (en) * 2004-12-23 2012-07-01 Kowa Co Treating agent for glaucoma
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
DE102005035986B4 (de) * 2005-07-28 2009-10-15 Bausch & Lomb Incorporated Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat
EP2334686B1 (en) 2008-08-28 2019-02-27 President and Fellows of Harvard College Cortistatin analogues and syntheses therof
EP2383286A1 (en) 2010-04-30 2011-11-02 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions for treatment of retinal degenerative diseases
JP2012180346A (ja) * 2011-02-10 2012-09-20 Santen Pharmaceut Co Ltd 親水性薬物の薬物移行性を改善した水性組成物
US20150038557A1 (en) 2012-02-24 2015-02-05 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and compositions for treatment of retinal degenerative diseases
PE20161405A1 (es) 2013-12-24 2017-01-18 Harvard College Analogos de cortistatina y sintesis y usos de los mismos
EP3294298A4 (en) 2015-05-08 2018-10-17 President and Fellows of Harvard College Cortistatin analogues, syntheses, and uses thereof
EP3316889A4 (en) 2015-07-01 2018-11-14 President and Fellows of Harvard College Cortistatin analogues and syntheses and uses thereof
EP3340982B1 (en) 2015-08-26 2021-12-15 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017143220A1 (en) 2016-02-17 2017-08-24 Children's Medical Center Corporation Ffa1 (gpr40) as a therapeutic target for neural angiogenesis diseases or disorders
WO2018005552A1 (en) 2016-06-27 2018-01-04 Achillion Pharmaceuticals, Inc. Quinazoline and indole compounds to treat medical disorders
WO2018033854A1 (en) 2016-08-15 2018-02-22 Santen Pharmaceutical Co., Ltd. Ophthalmic composition and a method for treating ocular hypertension and glaucoma
CN116726006A (zh) 2016-08-19 2023-09-12 阿拉西斯医药公司 眼科药物组合物及其相关用途
RS62817B1 (sr) * 2017-05-11 2022-02-28 Vyluma Inc Farmaceutske kompozicije atropina
CN111902141A (zh) 2018-03-26 2020-11-06 C4医药公司 用于ikaros降解的羟脑苷脂结合剂
JP2021535112A (ja) 2018-08-20 2021-12-16 アキリオン ファーマシューティカルズ，インコーポレーテッド 補体ｄ因子の医学的障害の治療のための医薬化合物
EP3866773A4 (en) 2018-10-16 2022-10-26 Georgia State University Research Foundation, Inc. CARBON MONOXIDE PRODRUGS FOR THE TREATMENT OF MEDICAL CONDITIONS
CA3205883A1 (en) * 2021-02-04 2022-08-11 Gregory I. Ostrow Ophthalmic compositions for presbyopia
EP4088713A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
EP4088714A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
CN113786380A (zh) * 2021-09-18 2021-12-14 华北制药股份有限公司 一种硝酸毛果芸香碱眼用凝胶及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US5252318A (en) * 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
FR2678832B1 (fr) * 1991-07-10 1995-03-17 Europhta Sa Laboratoire Nouvelles compositions ophtalmiques a resorption amelioree et leurs procedes de preparation.

Also Published As

Publication number Publication date
EE9600120A (et) 1997-04-15
DE752847T1 (de) 1997-09-04
NO964070L (no) 1996-11-28
SK123996A3 (en) 1997-06-04
AU2138995A (en) 1995-10-23
SK280492B6 (sk) 2000-03-13
EP0752847A1 (en) 1997-01-15
HK1013953A1 (en) 1999-09-17
HU223071B1 (hu) 2004-03-01
JPH10503470A (ja) 1998-03-31
KR100365914B1 (ko) 2003-04-16
DE69521686T2 (de) 2002-04-25
CA2186734A1 (en) 1995-10-12
ES2161874T3 (es) 2001-12-16
MX9603918A (es) 1997-04-30
PT752847E (pt) 2001-12-28
KR970702024A (ko) 1997-05-13
GR3036763T3 (en) 2001-12-31
EE03661B1 (et) 2002-04-15
US5710182A (en) 1998-01-20
BG63145B1 (bg) 2001-05-31
SE9401108D0 (sv) 1994-03-31
BR9507438A (pt) 1997-09-16
EP0752847B1 (en) 2001-07-11
DK0752847T3 (da) 2001-10-22
PL316584A1 (en) 1997-01-20
RO115409B1 (ro) 2000-02-28
BG100915A (en) 1997-07-31
AU694497B2 (en) 1998-07-23
CZ286596A3 (en) 1997-04-16
WO1995026711A1 (en) 1995-10-12
PL179433B1 (pl) 2000-09-29
HU9602691D0 (en) 1996-11-28
RU2139016C1 (ru) 1999-10-10
CN1144477A (zh) 1997-03-05
DE69521686D1 (de) 2001-08-16
NO314434B1 (no) 2003-03-24
CN1112918C (zh) 2003-07-02
HUT75666A (en) 1997-05-28
CZ290987B6 (cs) 2002-11-13
ATE202921T1 (de) 2001-07-15

Similar Documents

Publication Publication Date Title
NO964070D0 (no) Lav-viskositets opthalmisk blanding
NO964071D0 (no) Lav-viskositets opthalmisk blanding
US5945121A (en) Liposome eye drops
DE2900233C2 (de) Poliermittel, insbesondere für Augengläser aus organischem Material
WO1998005365A3 (en) Compositions and methods for disinfecting contact lenses and preserving contact lens care products
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
US2361624A (en) Stabilized therapeutic agents
DE60012068D1 (de) Zusammensetzung mit kontinuierlicher wässeriger Phase, die L-2-Oxothiazolidin- 4-carbonsäure enthält".
WO2009006130A2 (en) Salt free hyaluronate ophthalmic solution
JPS6452727A (en) Antiallergic eye drop
DE69914937T2 (de) Betablocker und carbopol enthaltende ophtalmische zusammensetzung
DE3625867A1 (de) Verwendung von tetrachlordecaoxid in der ophthalmologie
FI963744A (fi) Alennetun viskositeetin omaava oftalminen koostumus
DE1156250B (de) Loesung zur Behandlung von Kontaktlinsen

Legal Events

Date Code Title Description
MK1K Patent expired